反応式
CN1CCNCC1.COC(=O)c1cc(Br)cc([N+](=O)[O-])c1>C1COCCO1.CC1(C)c2cccc(P(c3ccccc3)c3ccccc3)c2Oc2c(P(c3ccccc3)c3ccccc3)cccc21.O=C(/C=C/c1ccccc1)/C=C/c1ccccc1.O=C(/C=C/c1ccccc1)/C=C/c1ccccc1.O=C(/C=C/c1ccccc1)/C=C/c1ccccc1.O=C([O-])[O-].[Cs+].[Cs+].[Pd].[Pd]>COC(=O)c1cc(N2CCN(C)CC2)cc([N+](=O)[O-])c1参加物
反応物 2
生成物 1
試薬・触媒・溶媒 4
反応条件
- 温度
- 110 °C
実験手順
To the stirred suspension ofmethyl 3-bromo-5-nitrobenzoate (2 g, 7.69 mmol) , cesium carbonate (12.53 g, 38.46 mmol) and (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine) (0.111 g, 0.19 mmol) in Dioxane (12 mL) (degassed with N2) was added pd (dba)3 (0.176 g, 0.19 mmol) and cesium carbonate (12.53 g, 38.46 mmol) AND rxn was heated at 110 ºC for 1 hr in microwaved. LCMS showed the m+1= 280. The crude raection mixture was filtered over celite. The filtrate was concentarted. The crude solid was diluted by 20 mL ethyl acetate, washed with 3x10 mL water, brine, collected the organic layers, concentrated. The crude solid was added to a silica gel column and was eluted with 0-10% methanol in DCM. Collected desired fractions. Obtained=1.4 gm. 1H NMR (300 MHz, DICHLOROMETHANE- _d_ 2) d ppm 2.32 (s, 3 H) 2.43 - 2.64 (m, 4 H) 3.13 - 3.40 (m, 4 H) 3.93 (s, 3 H) 7.85 (d, _J_ =1.70 Hz, 2H) 8.18 (t, _J_ =1.60 Hz, 1 H) Registered as AZ13477915.
出典と根拠
- ORDレコード
- ord-0986b91ec7734959810ebeac46571d3f
- 出典データセット
- 750 AstraZeneca ELN dataset
- 元リンク
- 出典を表示
関連ノート
読み込み中…